DE60135454D1 - Pharmazeutische gel-zusammensetzung - Google Patents

Pharmazeutische gel-zusammensetzung

Info

Publication number
DE60135454D1
DE60135454D1 DE60135454T DE60135454T DE60135454D1 DE 60135454 D1 DE60135454 D1 DE 60135454D1 DE 60135454 T DE60135454 T DE 60135454T DE 60135454 T DE60135454 T DE 60135454T DE 60135454 D1 DE60135454 D1 DE 60135454D1
Authority
DE
Germany
Prior art keywords
gel composition
pharmaceutical gel
treatment
pharmaceutical
abrasions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60135454T
Other languages
English (en)
Inventor
Robert Alan Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiltern Pharmaceuticals Pty Ltd
Original Assignee
Chiltern Pharmaceuticals Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiltern Pharmaceuticals Pty Ltd filed Critical Chiltern Pharmaceuticals Pty Ltd
Application granted granted Critical
Publication of DE60135454D1 publication Critical patent/DE60135454D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment
DE60135454T 2000-03-27 2001-03-26 Pharmazeutische gel-zusammensetzung Expired - Lifetime DE60135454D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ6476A AUPQ647600A0 (en) 2000-03-27 2000-03-27 Pharmaceutical gel composition
PCT/AU2001/000331 WO2001072310A1 (en) 2000-03-27 2001-03-26 Pharmaceutical gel composition

Publications (1)

Publication Number Publication Date
DE60135454D1 true DE60135454D1 (de) 2008-10-02

Family

ID=3820573

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60135454T Expired - Lifetime DE60135454D1 (de) 2000-03-27 2001-03-26 Pharmazeutische gel-zusammensetzung

Country Status (12)

Country Link
US (1) US6958159B2 (de)
EP (1) EP1282429B1 (de)
JP (1) JP2003528147A (de)
CN (1) CN100435807C (de)
AT (1) ATE405276T1 (de)
AU (1) AUPQ647600A0 (de)
BR (1) BR0109896A (de)
CA (1) CA2404210C (de)
DE (1) DE60135454D1 (de)
ES (1) ES2312421T3 (de)
NZ (1) NZ522051A (de)
WO (1) WO2001072310A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005045145A1 (de) * 2005-09-15 2007-03-29 Schülke & Mayr GmbH Verwendung von Octenidindihydrochlorid in halbfesten Zubereitungen
RU2317811C1 (ru) * 2006-06-19 2008-02-27 Лев Давидович Раснецов Фармацевтическая композиция для лечения ожогов (варианты) и способ ее получения (варианты)
CN101715349B (zh) 2007-05-08 2012-07-18 美国Rq生物科技有限公司 治疗革兰氏阴性细菌感染的治疗组合物及方法
CA2730009C (en) * 2007-07-12 2017-08-15 Whipbird Pain Relief Pty Ltd. Topical medicament
FR2927808B1 (fr) * 2008-02-26 2011-04-29 Fabre Pierre Dermo Cosmetique Gel de sucralfate sterilise
US9248160B1 (en) * 2015-07-28 2016-02-02 Zo Skin Health, Inc. Post-procedure skin care systems, compositions, and methods of use thereof
CN110732037B (zh) * 2018-07-20 2023-05-26 广州倍绣生物技术有限公司 止血糊剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068447A1 (en) * 1969-11-26 1971-08-27 Orsymonde Dehydrated pharmaceutical comps by - lyophilisation
US4604384A (en) * 1982-06-24 1986-08-05 Smith Robert A Pharmaceutical gel composition
AU558482B2 (en) * 1982-06-24 1987-01-29 Chiltern Pharmaceuticals Pty. Limited Pharmaceutical gel composition
JPH062150B2 (ja) * 1983-09-12 1994-01-12 リ−ドケミカル株式会社 貼付剤用基剤
US4618491A (en) * 1984-06-05 1986-10-21 Daicel Chemical Industries Ltd. Stable gel composition containing a carboxymethyl cellulose salt and a process for the preparation of them
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
US4840798A (en) * 1988-07-27 1989-06-20 Theon, Inc. Astringent gel composition and method for use
US5120544A (en) * 1989-06-19 1992-06-09 Henley International, Inc. Crosslinked hydrogel and method for making same
IL95642A0 (en) * 1989-09-15 1991-06-30 Pehrom Pharmaceutical Corp Topical preparations for treatment of ulcers and other lesions
JP3132863B2 (ja) * 1991-10-24 2001-02-05 富山化学工業株式会社 徐放性口腔用軟膏
JPH07223938A (ja) * 1994-02-09 1995-08-22 Saitama Daiichi Seiyaku Kk 貼付剤基剤
JPH0984869A (ja) * 1995-09-25 1997-03-31 Lion Corp 貼付剤
JPH11286448A (ja) * 1998-04-01 1999-10-19 Showa Yakuhin Kako Kk ミノサイクリン含有組成物
JP4275768B2 (ja) * 1998-06-18 2009-06-10 久光製薬株式会社 水性粘着膏体

Also Published As

Publication number Publication date
NZ522051A (en) 2004-08-27
CA2404210C (en) 2009-11-03
BR0109896A (pt) 2003-06-03
AUPQ647600A0 (en) 2000-04-20
US20030147942A1 (en) 2003-08-07
CA2404210A1 (en) 2001-10-04
EP1282429A1 (de) 2003-02-12
CN100435807C (zh) 2008-11-26
WO2001072310A1 (en) 2001-10-04
ES2312421T3 (es) 2009-03-01
US6958159B2 (en) 2005-10-25
ATE405276T1 (de) 2008-09-15
CN1419453A (zh) 2003-05-21
EP1282429A4 (de) 2005-12-21
JP2003528147A (ja) 2003-09-24
EP1282429B1 (de) 2008-08-20

Similar Documents

Publication Publication Date Title
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
DOP2000000114A (es) Oxazolidinonas substituidas y su uso
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
ES2177084T3 (es) Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso.
CY1108633T1 (el) Κοσμητικη συνθεση βασεως σουκραλφατ και θειικων αλατων χαλκου και ψευδαργυρου
CY1105125T1 (el) Χρηση αναστολεων ακετυλοχολινεστepασης για την παρασκευη φαρμακευτικων συνθεσεων για τη θepαπευτικη αντιμετωπιση συνδρομων λειτουργικων και/ή οργανικων πονων
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
BR0316776A (pt) Formula para anti-infeccioso tópico
ATE269113T1 (de) Sprühfähige wundversorgungszusammensetzung
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
TR199802769T2 (xx) Terpenoid bileşikler ile antihistaminik bileşiklerin bir kombinasyonunu ihtiva eden topikal bileşim.
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
BRPI0208411B8 (pt) composto, composição farmacêutica tópica para tratamento profilático ou terapêutico de doenças sexualmente transmitidas em um paciente humano, e, uso de um composto
ES2178405T3 (es) Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.
DE60135454D1 (de) Pharmazeutische gel-zusammensetzung
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
WO2003007876A3 (en) N-fatty acid-amino acid conjugates and therapeutic uses
DK0951294T3 (da) Sårhelende formuleringer indeholdende humanplasmafibronectin
AU2002212489A1 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition